Skip header and navigation

6 records – page 1 of 1.

ACEi and ARBS in Hypertension and Heart Failure

https://libcat.nshealth.ca/en/permalink/provcat39106
Pasquale Perrone Filardi, editor. --Cham: Springer International Publishing : Imprint: Springer ; ISCP , c2015.
Available Online
View e-Book
Location
Online
This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewi…
Available Online
View e-Book
Other Authors
Perrone Filardi, Pasquale
Other Authors
International Society of Cardiovascular Pharmacotherapy
Responsibility
Pasquale Perrone Filardi, editor
Alternate Title
Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in hypertension and heart failure
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Springer ; ISCP
Date of Publication
c2015
Physical Description
1 online resource (x, 150 p. : 19 illus., 13 illus. in color)
Series Title
Current cardiovascular therapy
ISBN
9783319097886
9783319097879 (print ed.)
Subjects (MeSH)
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors - pharmacology
Heart Failure - drug therapy
Hypertension - drug therapy
Renin-Angiotensin System
Abstract
This book summarizes how the renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction and reviews the action of angiotensin converting enzyme inhibitors and AT1 receptor antagonists on reducing morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. ACEi and ARBS in Hypertension and Heart Failure is a highly practical reference reviewing the evidence and providing a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It is written in an easy-to-follow format and with many illustrations to aid clarity and the assimilation of information. Each chapter is written by established authorities in their fields who are also experienced in explaining often complex concepts. The result is a unique book which is not only comprehensive but also clear and useful for the busy medical practitioner.
Contents
1. Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension -- 2. ACE Inhibitor and Renin–Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure -- 3. Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System: Inhibitors in Patients with Hypertension and Heart Failure -- 4. Target Organ Damage and RAAS Blockade.
Format
e-Book
Location
Online
Less detail
IWK. Pharmacy. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1204
Available Online
View Pamphlet
Captopril - This medicine is used to treat high blood pressure and heart failure. Captopril is a medicine that lowers blood pressure and reduces the amount of work the heart has to do.
Available Online
View Pamphlet
Corporate Author
IWK. Pharmacy
Alternate Title
Dissolve-A-Dose® System
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Antihypertensive Agents
Captopril
Hypertension - drug therapy
Subjects (LCSH)
Captopril
Hypertension--Chemotherapy
Hypotensive agents
Abstract
Captopril - This medicine is used to treat high blood pressure and heart failure. Captopril is a medicine that lowers blood pressure and reduces the amount of work the heart has to do.
Responsibility
IWK NICU Pharmacy Team, Halifax, NS
Pamphlet Number
PL-1204
Less detail

Drug Adherence in Hypertension and Cardiovascular Protection

https://libcat.nshealth.ca/en/permalink/provcat43140
Michel Burnier, editor. --Cham: Springer , c2018.
Available Online
View e-Book
Location
Online
This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complic…
Available Online
View e-Book
Other Authors
Burnier, Michel
Other Authors
European Society of Hypertension
Responsibility
Michel Burnier, editor
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (viii, 314 p.) : 43 illus., 30 illus. in color
Series Title
Updates in hypertension and cardiovascular protection
ISBN
9783319765938
9783319765921 (print ed.)
9783319765945 (print ed.)
ISSN
2366-4606
Subjects (MeSH)
Cardiovascular Diseases - drug therapy
Hypertension - drug therapy
Medication Adherence
Risk Factors
Specialty
Cardiology
Pharmacy
Abstract
This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of several interventions aimed at improving drug adherence and put particular emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists. The volume also includes a careful analysis of the health and economic impact of poor adherence. The book is aimed at physicians, pharmacists, students and all health professionals dealing not only with hypertension or dyslipidemia, but also with chronic asymptomatic diseases such as diabetes, HIV or chronic respiratory diseases.
Contents
1. Taxonomy of Medication Adherence: Recent Developments -- Part I. Measuring Drug Adherence -- 2. Qualitative Assessments of Adherence -- 3. Electronic Monitoring of Medication Adherence: From Dose-Counting to Dose-Clocking -- 4. Measurements of Antihypertensive Medications in Blood and Urine -- 5. Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the Lombardy Database -- 6. Directly Observed Therapy in Hypertension (DOT-HTN) -- 7. Digital Medicines to Measure Drug Ingestion Adherence -- 8. Ethical Aspects of Measuring Adherence to Antihypertensive Treatment -- Part II. Risk Factors for Non-adherence -- 9. Determinants and Barriers to Adherence in Hypertension 10. Beliefs and Adherence in Hypertension and Cardiovascular Protection -- Part III. Adherence in Hypertension and CV Protection -- 11. Impact of Drug Adherence in Clinical Trials -- 12. The Impact of Antihypertensive Drugs on Adherence -- 13. Medication Persistence in Hypertension in General Practice -- 14. Drug Adherence in Resistant Hypertension -- 15. Drug Adherence with Cardiovascular Medicines: Statins and Aspirin -- 16. Which Interventions Are Useful? -- 17. Use of Fixed-Dose Combinations in Hypertension and Cardiovascular Disease Prevention -- 18. Nurse Led Interventions in Hypertension -- 19. Role of the Pharmacist in Supporting Adherence -- 20. Integrated Approaches to Support Medication Adherence: The Case of Hypertension - 21. Use of Apps to Improve Drug Adherence in Hypertensive Patients -- Part IV. Health Care Consequences of Non-adherence -- 22. Global Clinical Consequences of Poor Adherence.
Format
e-Book
Location
Online
Less detail

Hypertension and Organ Damage : A Case-Based Guide to Management

https://libcat.nshealth.ca/en/permalink/provcat39972
Giuliano Tocci. (1st ed.) --Cham: Springer , c2016.
Available Online
View e-Book
Location
Online
This book is designed to assist physicians in choosing among diagnostic procedures and therapeutic options when caring for patients with hypertension and markers of organ damage. The comprehensive description of practical clinical cases sets this book apart from other publications and will help the reader to transfer general guideline recommendations to the clinical setting. With this purpose, the cases have been selected to reflect situations frequently encountered during clinical routine, rat…
Available Online
View e-Book
Author
Tocci, Giuliano
Responsibility
Giuliano Tocci
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2016
Physical Description
1 online resource (xiii, 119 p. : 60 illus., 30 illus. in color)
Series Title
Practical case studies in hypertension management
ISBN
9783319250977
9783319250953 (print ed.)
ISSN
2364-6632
Subjects (MeSH)
Antihypertensive Agents - therapeutic use
Biomarkers - metabolism
Comorbidity
Hypertension - complications
Hypertension - drug therapy
Abstract
This book is designed to assist physicians in choosing among diagnostic procedures and therapeutic options when caring for patients with hypertension and markers of organ damage. The comprehensive description of practical clinical cases sets this book apart from other publications and will help the reader to transfer general guideline recommendations to the clinical setting. With this purpose, the cases have been selected to reflect situations frequently encountered during clinical routine, rather than hypertensive crises or emergencies or the rare presentations that tend to be addressed in case reports in scientific journals. The scenarios considered include treated hypertension with uncontrolled blood pressure levels in patients with left ventricular hypertrophy, diastolic dysfunction, carotid atherosclerosis, microalbuminuria and renal impairment, proteinuria and renal disease, and abnormal pulse pressure. By representing clinical practice in a "real world" setting, these paradigmatic cases will enable the practitioner to select the diagnostic tools and form of treatment best suited to the individual patient and the particular cardiovascular risk profile, thereby optimizing outcomes.
Contents
Case 1. Patient with essential hypertension and left ventricular hypertrophy -- Case 2. Patient with essential hypertension and diastolic dysfunction -- Case 3. Patient with essential hypertension and microalbuminuria -- Case 4. Patient with essential hypertension and proteinuria -- Case 5. Patient with essential hypertension and atherosclerosis -- Case 6. Patient with essential hypertension and high pulse pressure.
Format
e-Book
Publication Type
Case Reports
Location
Online
Less detail

Hypertension in the Elderly

https://libcat.nshealth.ca/en/permalink/provcat28307
edited by L. Michael Prisant. --Totowa, NJ: Humana Press , c2005.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Prisant, L. Michael
Responsibility
edited by L. Michael Prisant
Place of Publication
Totowa, NJ
Publisher
Humana Press
Date of Publication
c2005
Series Title
Clinical hypertension and vascular diseases
ISBN
9781592599110
Subjects (MeSH)
Hypertension - etiology
Hypertension - drug therapy
Antihypertensive Agents - therapeutic use
Subjects (LCSH)
Cardiology
Geriatrics
Format
e-Book
Location
Online
Less detail
IWK. NICU Pharmacy. Halifax, NS: IWK Health Centre , 2019.
Pamphlet Number
PL-1212
Available Online
View Pamphlet
Propranolol is used to treat some types of heart conditions or to lower high blood pressure. It is also used to treat hemangiomas.
Available Online
View Pamphlet
Corporate Author
IWK. NICU Pharmacy
Place of Publication
Halifax, NS
Publisher
IWK Health Centre
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document : digital, PDF file
Subjects (MeSH)
Antihypertensive Agents
Heart Diseases - drug therapy
Hypertension - drug therapy
Pharmaceutical Preparations
Propranolol
Subjects (LCSH)
Heart--Diseases--Chemotherapy
Hypotensive agents
Abstract
Propranolol is used to treat some types of heart conditions or to lower high blood pressure. It is also used to treat hemangiomas.
Responsibility
IWK NICU Pharmacy Team, Halifax, NS
Pamphlet Number
PL-1212
Less detail

6 records – page 1 of 1.